These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 17995974)
1. Response to 'Communicating information about drug interactions'. Back DJ; Gibbons SE Br J Clin Pharmacol; 2008 Apr; 65(4):617-8. PubMed ID: 17995974 [No Abstract] [Full Text] [Related]
2. Epilepsy: Issues with antiepileptic drug use in HIV-infected patients. Brew BJ; Thompson J Nat Rev Neurol; 2012 Mar; 8(4):187-8. PubMed ID: 22410581 [No Abstract] [Full Text] [Related]
3. Stopping antiretroviral therapy: role for therapeutic drug monitoring. Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237 [No Abstract] [Full Text] [Related]
4. Exploring the use of novel drug delivery systems for antiretroviral drugs. Ojewole E; Mackraj I; Naidoo P; Govender T Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830 [TBL] [Abstract][Full Text] [Related]
5. The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery? Whitlock GG; Patel A; Edwards SG; Benn PD; Miller RF Clin Med (Lond); 2012 Jun; 12(3):300-1. PubMed ID: 22783792 [No Abstract] [Full Text] [Related]
6. Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review. Cattaneo D; Baldelli S; Cozzi V; Clementi E; Marriott DJE; Gervasoni C; Ther Drug Monit; 2020 Feb; 42(1):64-74. PubMed ID: 31393332 [TBL] [Abstract][Full Text] [Related]
7. The critical need for alternative antiretroviral formulations, and obstacles to their development. Swindells S; Flexner C; Fletcher CV; Jacobson JM J Infect Dis; 2011 Sep; 204(5):669-74. PubMed ID: 21788451 [No Abstract] [Full Text] [Related]
8. Key Principles of Antiretroviral Pharmacology. Dionne B Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145 [TBL] [Abstract][Full Text] [Related]
9. [Determination of serum levels of antiretroviral drugs]. Kurowski M MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053 [No Abstract] [Full Text] [Related]
14. Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tube. Taegtmeyer AB; Müller V; Kovari H; Kullak-Ublick GA; Corti N AIDS; 2011 Jun; 25(10):1339-41. PubMed ID: 21659798 [No Abstract] [Full Text] [Related]
15. Successful absorption of antiretroviral drugs after gastrojejunal bypass surgery following failure of therapy through a jejunal tube. Kamimura M; Watanabe K; Kobayakawa M; Mihara F; Edamoto Y; Teruya K; Kikuchi Y; Oka S Intern Med; 2009; 48(12):1103-4. PubMed ID: 19525608 [TBL] [Abstract][Full Text] [Related]
16. Response to: Pharmacokinetic and Pharmacodynamic Drug Interactions between Antiretrovirals and Oral Contraceptives. Atrio JM Clin Pharmacokinet; 2015 May; 54(5):563-4. PubMed ID: 25701379 [No Abstract] [Full Text] [Related]
17. Antiretroviral drug treatment of CNS HIV-1 infection. Yilmaz A; Price RW; Gisslén M J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207 [TBL] [Abstract][Full Text] [Related]
18. Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection. Med Lett Drugs Ther; 2003 Nov; 45(1169):90-2. PubMed ID: 14603099 [No Abstract] [Full Text] [Related]
19. Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents. Winston A; Garvey L; Sabin CA AIDS; 2011 Apr; 25(7):1014-5. PubMed ID: 21487256 [No Abstract] [Full Text] [Related]